항정신병약 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 예측 기간 동안의 성장은 정신분열증 및 양극성 장애 발병률 증가, 정부의 지원 정책 및 자금 지원, 개인 맞춤형 의약품에 대한 수요 증가, 부작용 감소에 대한 집중, 그리고 정신 건강 옹호 및 지원 그룹의 증가에 기인할 수 있습니다.
정신장애의 유병률 상승은 향후 몇 년간의 항정신병약 시장의 성장을 가속할 것으로 예상됩니다. 신위생상의 문제를 일으킬 가능성이 있습니다.항정신병약은 신경전달물질(주로 도파민과 세로토닌)의 활성을 조정함으로써, 이러한 장애를 관리해, 정신병 증상을 완화해, 기분을 안정시키고, 인지 및 감정 기능을 높이는데 도움이 됩니다. 예를 들면, 2023년 남용 및 정신 건강 서비스국(SAMHSA)의 조사에 따르면, 18세 이상의 성인의 약 6%, 1,540만명이 심각한 정신질환(SMI)을 경험하고 있는 것으로 밝혀졌습니다. 2024년 9월 호주 정부 기관인 호주 보건복지연구소는 호주에서 치매를 앓고 있는 사람들의 수가 2023년의 약 41만 1,100명에서 2058년에는 84만 9,300명으로 2배 이상이 될 것으로 예측했습니다.
항정신병약 시장의 주요 기업은 기존의 경구약과 비교하여 환자의 컴플라이언스와 효능을 향상시키기 위해 피하 투여의 비정형 항정신병약 주사제와 같은 선진 의료제품을 개발하고 있습니다. Pharmaceutical Industries Ltd.와 프랑스의 생물학적 제제 제조업체 MedinCell SA는 FDA 승인 리스페리돈의 서방형 주사제인 UZEDY를 발표했습니다. 시간 내에 치료 수준에 도달하는 안정한 약물 방출을 실현합니다. 임상시험은 위제와 비교하여 정신 분열증의 재발 위험을 최대 80% 감소시키는 것으로 나타났으며 경구 항 정신병 약물에서 흔히 볼 수있는 복약 어드밴스 문제를 해결합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 항정신병약 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 항정신병약 시장 : 성장률 분석
- 세계의 항정신병약 시장 실적 : 규모와 성장, 2019-2024
- 세계의 항정신병약 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 항정신병약 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 항정신병약 시장 : 치료 클래스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 제1세대
- 제2세대
- 제3세대
- 세계의 항정신병약 시장 : 질환별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 정신분열증
- 양극성 장애
- 단극성 우울증
- 치매
- 기타 병
- 세계의 항정신병약 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 약국
- 온라인 약국
- 세계의 항정신병약 시장 : 제1세대별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 정형항정신병약
- 페노티아진
- 부티로페논
- 티옥산텐
- 디벤조옥사제핀
- 세계의 항정신병약 시장 : 2세대 하위 세분화, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 비정형 항정신병약
- 클로자핀
- 올란자핀
- 리스페리돈
- 퀘티아핀
- 아리피프라졸
- 팔리페리돈
- 루라시돈
- 세계의 항정신병약 시장 : 제3세대별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 부분 도파민 작용제
- 아리피프라졸
- 브렉스피프라졸
- 칼리프라진
제7장 지역별, 국가별 분석
- 세계의 항정신병약 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 항정신병약 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 항정신병약 시장 : 경쟁 구도
- 항정신병약 시장 : 기업 프로파일
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- AstraZeneca PLC
- GlaxoSmithKline PLC
- Takeda Pharmaceutical Company Limited
- Eli Lilly And Company
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Otsuka Pharmaceutical Co. Ltd.
- Aurobindo Pharma Ltd.
- Cipla Ltd.
- H. Lundbeck A/S
- Dr. Reddy's Laboratories Ltd.
- Intas Pharmaceuticals Ltd.
- Apotex Inc.
- Lupin Limited
- Glenmark Pharmaceuticals Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 항정신병약 시장 2029 : 새로운 기회를 제공하는 국가
- 항정신병약 시장 2029 : 새로운 기회를 제공하는 부문
- 항정신병약 시장 2029 : 성장 전략
제36장 부록
SHW
Antipsychotic drugs are medications primarily used to manage and treat symptoms of psychosis, including delusions, hallucinations, paranoia, and disordered thinking. Psychosis is often linked with psychiatric conditions such as schizophrenia, bipolar disorder, and severe depression. These medications are also known as neuroleptics or major tranquilizers.
Antipsychotic drugs are classified into first-generation, second-generation, and third-generation categories. First-generation drugs, the earliest developed, primarily work by blocking dopamine receptors in the brain, which helps alleviate hallucinations and delusions. They are prescribed for various conditions, including schizophrenia, bipolar disorder, unipolar depression, and dementia. These drugs are available through multiple distribution channels, such as hospital pharmacies, drug stores, and online pharmacies.
The antipsychotic drugs market research report is one of a series of new reports from The Business Research Company that provides antipsychotic drugs market statistics, including the antipsychotic drugs industry global market size, regional shares, competitors with the antipsychotic drugs market share, detailed antipsychotic drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the antipsychotic drugs industry. These antipsychotic drugs market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The antipsychotic drugs market size has grown rapidly in recent years. It will grow from $19.5 billion in 2024 to $21.45 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to the rising prevalence of mental health disorders, development of second-generation antipsychotics, growing geriatric population, improvements in healthcare infrastructure, and high investment in research and development.
The antipsychotic drugs market size is expected to see strong growth in the next few years. It will grow to $31.04 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the increasing incidence of schizophrenia and bipolar disorder, supportive government policies and funding, rising demand for personalized medicine, focus on reducing side effects, and growing mental health advocacy and support groups. Major trends in the forecast period include integration of digital health tools for monitoring, development of novel mechanisms of action, increasing focus on combination therapies, adoption of pharmacogenomics for tailored treatments, emphasis on patient-centric drug development.
The rising prevalence of mental disorders is anticipated to drive the growth of the antipsychotic drug market in the coming years. Mental disorders, also referred to as mental illnesses, affect an individual's thinking, behavior, mood, and overall mental health. Various factors such as stress, societal pressures, genetic predispositions, biochemical imbalances, neurodevelopmental issues, and physical health conditions can contribute to mental health problems. Antipsychotic drugs help manage these disorders by modifying the activity of neurotransmitters, mainly dopamine and serotonin, to alleviate psychotic symptoms, stabilize mood, and enhance cognitive and emotional functioning. For example, in November 2023, a survey by the Substance Abuse and Mental Health Services Administration (SAMHSA), a U.S.-based public health agency, revealed that about 6% of adults aged 18 and older, or 15.4 million people, reported experiencing serious mental illness (SMI). Additionally, in September 2024, the Australian Institute of Health and Welfare, an Australian government agency, projected that the number of people living with dementia in Australia will more than double, from approximately 411,100 in 2023 to 849,300 by 2058. This increase is expected to impact around 315,500 men and 533,800 women. As such, the growing incidence of mental disorders is fueling the expansion of the antipsychotic drug market.
Leading companies in the antipsychotic drug market are developing advanced medical products, such as subcutaneous atypical antipsychotic injections, to improve patient compliance and efficacy compared to traditional oral medications. These injections are administered under the skin and help in maintaining stable medication levels and better symptom control. For example, in April 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, and MedinCell SA, a French manufacturer of biological products, introduced UZEDY, an FDA-approved extended-release injectable formulation of risperidone. This long-acting subcutaneous injection offers flexible dosing intervals of one or two months and employs MedinCell's proprietary SteadyTeq technology for consistent medication release, reaching therapeutic levels within 6-24 hours of administration. Clinical trials showed that UZEDY reduced the risk of schizophrenia relapse by up to 80% compared to a placebo, addressing adherence issues commonly associated with oral antipsychotics.
In March 2024, Bristol-Myers Squibb, a US-based pharmaceutical firm, acquired Karuna Therapeutics Inc. for $14 billion. This acquisition aims to significantly enhance Bristol-Myers Squibb's neuroscience portfolio by integrating Karuna's innovative antipsychotic treatment, KarXT. The deal also provides access to Karuna's early-stage and preclinical pipeline, potentially contributing to Bristol-Myers Squibb's long-term growth and diversification in neuroscience. Karuna Therapeutics Inc. is a US-based clinical-stage biopharmaceutical company focused on developing treatments for psychiatric and neurological conditions.
Major companies operating in the antipsychotic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkermes plc
North America was the largest region in the antipsychotic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the antipsychotic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The antipsychotic drugs market consists of sales of long-acting injectables, depot injections, and atypical antipsychotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antipsychotic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antipsychotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for antipsychotic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antipsychotic drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Therapeutic Class: First Generation; Second Generation; Third Generation
- 2) By Disease: Schizophrenia; Bipolar Disorder; Unipolar Depression; Dementia; Other Diseases
- 3) By Distribution Channel: Hospital Pharmacies; Drug Stores; Online Pharmacies
- Subsegments:
- 1) By First Generation: Typical Antipsychotics; Phenothiazines; Butyrophenones; Thioxanthenes; Dibenzoxazepines
- 2) By Second Generation: Atypical Antipsychotics; Clozapine; Olanzapine; Risperidone; Quetiapine; Aripiprazole; Paliperidone; Lurasidone
- 3) By Third Generation: Partial Dopamine Agonists; Aripiprazole; Brexpiprazole; Cariprazine
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck And Co. Inc.; AbbVie Inc.; Bristol-Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Antipsychotic Drugs Market Characteristics
3. Antipsychotic Drugs Market Trends And Strategies
4. Antipsychotic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Antipsychotic Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Antipsychotic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Antipsychotic Drugs Market Growth Rate Analysis
- 5.4. Global Antipsychotic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Antipsychotic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Antipsychotic Drugs Total Addressable Market (TAM)
6. Antipsychotic Drugs Market Segmentation
- 6.1. Global Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- First Generation
- Second Generation
- Third Generation
- 6.2. Global Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Schizophrenia
- Bipolar Disorder
- Unipolar Depression
- Dementia
- Other Diseases
- 6.3. Global Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- 6.4. Global Antipsychotic Drugs Market, Sub-Segmentation Of First Generation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Typical Antipsychotics
- Phenothiazines
- Butyrophenones
- Thioxanthenes
- Dibenzoxazepines
- 6.5. Global Antipsychotic Drugs Market, Sub-Segmentation Of Second Generation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Atypical Antipsychotics
- Clozapine
- Olanzapine
- Risperidone
- Quetiapine
- Aripiprazole
- Paliperidone
- Lurasidone
- 6.6. Global Antipsychotic Drugs Market, Sub-Segmentation Of Third Generation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Partial Dopamine Agonists
- Aripiprazole
- Brexpiprazole
- Cariprazine
7. Antipsychotic Drugs Market Regional And Country Analysis
- 7.1. Global Antipsychotic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Antipsychotic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Antipsychotic Drugs Market
- 8.1. Asia-Pacific Antipsychotic Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Antipsychotic Drugs Market
- 9.1. China Antipsychotic Drugs Market Overview
- 9.2. China Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Antipsychotic Drugs Market
- 10.1. India Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Antipsychotic Drugs Market
- 11.1. Japan Antipsychotic Drugs Market Overview
- 11.2. Japan Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Antipsychotic Drugs Market
- 12.1. Australia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Antipsychotic Drugs Market
- 13.1. Indonesia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Antipsychotic Drugs Market
- 14.1. South Korea Antipsychotic Drugs Market Overview
- 14.2. South Korea Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Antipsychotic Drugs Market
- 15.1. Western Europe Antipsychotic Drugs Market Overview
- 15.2. Western Europe Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Antipsychotic Drugs Market
- 16.1. UK Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Antipsychotic Drugs Market
- 17.1. Germany Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Antipsychotic Drugs Market
- 18.1. France Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Antipsychotic Drugs Market
- 19.1. Italy Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Antipsychotic Drugs Market
- 20.1. Spain Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Antipsychotic Drugs Market
- 21.1. Eastern Europe Antipsychotic Drugs Market Overview
- 21.2. Eastern Europe Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Antipsychotic Drugs Market
- 22.1. Russia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Antipsychotic Drugs Market
- 23.1. North America Antipsychotic Drugs Market Overview
- 23.2. North America Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Antipsychotic Drugs Market
- 24.1. USA Antipsychotic Drugs Market Overview
- 24.2. USA Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Antipsychotic Drugs Market
- 25.1. Canada Antipsychotic Drugs Market Overview
- 25.2. Canada Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Antipsychotic Drugs Market
- 26.1. South America Antipsychotic Drugs Market Overview
- 26.2. South America Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Antipsychotic Drugs Market
- 27.1. Brazil Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Antipsychotic Drugs Market
- 28.1. Middle East Antipsychotic Drugs Market Overview
- 28.2. Middle East Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Antipsychotic Drugs Market
- 29.1. Africa Antipsychotic Drugs Market Overview
- 29.2. Africa Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Antipsychotic Drugs Market Competitive Landscape And Company Profiles
- 30.1. Antipsychotic Drugs Market Competitive Landscape
- 30.2. Antipsychotic Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Antipsychotic Drugs Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. GlaxoSmithKline PLC
- 31.3. Takeda Pharmaceutical Company Limited
- 31.4. Eli Lilly And Company
- 31.5. Teva Pharmaceutical Industries Ltd.
- 31.6. Sun Pharmaceutical Industries Ltd.
- 31.7. Otsuka Pharmaceutical Co. Ltd.
- 31.8. Aurobindo Pharma Ltd.
- 31.9. Cipla Ltd.
- 31.10. H. Lundbeck A/S
- 31.11. Dr. Reddy's Laboratories Ltd.
- 31.12. Intas Pharmaceuticals Ltd.
- 31.13. Apotex Inc.
- 31.14. Lupin Limited
- 31.15. Glenmark Pharmaceuticals Ltd.
32. Global Antipsychotic Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Antipsychotic Drugs Market
34. Recent Developments In The Antipsychotic Drugs Market
35. Antipsychotic Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Antipsychotic Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Antipsychotic Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Antipsychotic Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
